Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

UPDATE 1-Amgen, Arrowhead team up on gene-therapies for heart disease

By: Reuters: Company News
Sept 29 (Reuters) - Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and collaborate with the company to develop gene-silencing therapies for heart disease.
Related Stocks:
Alnylam Pharmaceuticals Amgen Arrowhead Pharma Ionis Pharmaceuticals Novan Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.